Literature DB >> 3923884

15-Hydroxyeicosatetraenoic acid is a potent inflammatory mediator and agonist of canine tracheal mucus secretion.

H G Johnson, M L McNee, F F Sun.   

Abstract

It was shown that 15-hydroxyeicosatetraenoic acid (15-HETE) but not 15-H(P)ETE or 5-HETE is a potent agonist for secretion of glycoprotein-containing mucus from the in vivo canine trachea. Given by aerosol into the lungs or by intra-arterial injection into the trachea, 15 HETE also caused the chemotaxis of inflammatory cells into the lumen of the airways. Accompanying this inflammatory cell infiltrate was an increase (183%, p less than 0.05) of expiration of fluid in the partially saturated air coming from the lung. The levels of 15-HETE extracted from tracheal mucus correlated well with hillocks and weight of secreted mucus found in the mucus after hypoxia or after arachidonic acid loading. Indomethacin and atropine blocked the mucus secretagogue effect of 15-HETE in the trachea. Indomethacin and U-52, 412 (a 15-lipoxygenase inhibitor) pretreatment abolished a portion of the 15-HETE-induced enhancement of mucus weight and 15-HETE level in the secretion.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3923884     DOI: 10.1164/arrd.1985.131.6.917

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  14 in total

1.  Hydroxyeicosatetraenoic acid metabolism in cultured human skin fibroblasts. Evidence for peroxisomal beta-oxidation.

Authors:  J A Gordon; P H Figard; A A Spector
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

Review 2.  Late-phase IgE-mediated reactions.

Authors:  R F Lemanske; M Kaliner
Journal:  J Clin Immunol       Date:  1988-01       Impact factor: 8.317

3.  Inverse relationship between 15-lipoxygenase-2 and PPAR-gamma gene expression in normal epithelia compared with tumor epithelia.

Authors:  Vemparala Subbarayan; Xiao-Chun Xu; Jeri Kim; Peiying Yang; Ashraful Hoque; Anita L Sabichi; Norma Llansa; Gabriella Mendoza; Christopher J Logothetis; Robert A Newman; Scott M Lippman; David G Menter
Journal:  Neoplasia       Date:  2005-03       Impact factor: 5.715

4.  Differential gene expression mediated by 15-hydroxyeicosatetraenoic acid in LPS-stimulated RAW 264.7 cells.

Authors:  Alexandra C Schrimpe; David W Wright
Journal:  Malar J       Date:  2009-08-11       Impact factor: 2.979

5.  MUC1 expression in Sjogren's syndrome, KCS, and control subjects.

Authors:  Barbary Caffery; Miriam L Heynen; Elizabeth Joyce; Lyndon Jones; Robert Ritter; Michelle Senchyna
Journal:  Mol Vis       Date:  2010-08-24       Impact factor: 2.367

6.  Granulocyte chemotaxis in the canine trachea: inhibition by lipid mediator antagonists and systemic inhibitors.

Authors:  H G Johnson; M L McNee
Journal:  Agents Actions       Date:  1991-07

7.  Effect of inhaled 15-(s)-hydroxyeicosatetraenoic acid on tracheobronchial clearance in normal human airways.

Authors:  C K Lai; R Polosa; D Pavia; A Hasani; J E Agnew; S W Clarke; S T Holgate
Journal:  Thorax       Date:  1991-06       Impact factor: 9.139

8.  Tulathromycin exerts proresolving effects in bovine neutrophils by inhibiting phospholipases and altering leukotriene B4, prostaglandin E2, and lipoxin A4 production.

Authors:  Carrie D Fischer; Stephanie C Duquette; Bernard S Renaux; Troy D Feener; Douglas W Morck; Morley D Hollenberg; Merlyn J Lucas; Andre G Buret
Journal:  Antimicrob Agents Chemother       Date:  2014-05-12       Impact factor: 5.191

9.  MUC5AC mucin release from human airways in vitro: effects of indomethacin and Bay X1005.

Authors:  P Roger; J P Gascard; J Bara; V T de Montpreville; C Brink
Journal:  Mediators Inflamm       Date:  2001-02       Impact factor: 4.711

10.  MUC16 expression in Sjogren's syndrome, KCS, and control subjects.

Authors:  Barbara Caffery; Elizabeth Joyce; Miriam L Heynen; Lyndon Jones; Robert Ritter; Daniel A Gamache; Michelle Senchyna
Journal:  Mol Vis       Date:  2008-12-30       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.